Ansell Healthcare, a leader in healthcare barrier protective products, recently entered into two separate three-year supplier agreements with Consorta, Inc., a leading healthcare resource management and healthcare group purchasing organization headquartered in Chicago.Â
Effective April 1, 2006 through March 31, 2009, the dual agreement awards Ansell preferred supplier status for its complete lines of surgical and examination gloves, including the newest latex-free Derma Prene® PI surgical glove and Ansells full range of surgical latex gloves with SureFit Technology. Ansell also offers a powdered surgical glove to accommodate those facilities, which require an economical surgical glove. Furthermore, Ansell will continue to provide complimentary consultative programs to all Consorta members with an emphasis on glove management and utilization, risk management analysis, and continuing education programs.
We are please to continue our relationship with Ansell, said Vince Viverito, director of medical supplies and surgical services. The addition of several new surgical glove products rounds out their line for our members and offers our surgeons and nurses a choice.
Ansell is fully committed to developing and providing our customers with an extensive line of barrier protective products, clinical education, and service excellence, remarked Bobbie Camp, director of national accounts for Ansell. We value our long-term relationship with Consorta. Consorta will continue to benefit from being aligned with the right supplier and consistently receive the best service, value, and products on the market.
Source: Ansell Ltd.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.
The Neglected Tropical Diseases You’ve Never Heard Of
February 27th 2024The 20 conditions, known as neglected tropical diseases (NTDs), are estimated to affect more than 1 billion people, yet many individuals have never heard of them. Heather Saunders, MPH, RN, CIC, discusses 5 of them and what is being done to prevent their spread.